Health care may not have a speedy recovery, despite tariff relief

26th September 2025

The share prices of some of the world’s largest health care companies have rallied a bit today, despite Donald Trump’s announcement yesterday of a tariff of 100% on US imports of branded or patented pharmaceutical products from 1st October. That’s probably because investors were braced for bad news, which could have been worse. But even if tariffs aren’t such a big deal after all for the global health care sector, it faces other headwinds. So its recovery may be slow.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.

Business Email

Country

Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.

Already a client or trialist? Log in to read this.